title: Failure of tocilizumab treatment in a CINCA patient: clinical and pathogenic implications.
authors.forename: Ludmila S
authors.initials: LS
authors.lastname: Snegireva
authors.forename: Mikhail M
authors.initials: MM
authors.lastname: Kostik
authors.forename: Francesco
authors.initials: F
authors.lastname: Caroli
authors.forename: Isabella
authors.initials: I
authors.lastname: Ceccherini
authors.forename: Marco
authors.initials: M
authors.lastname: Gattorno
authors.forename: Vyacheslav G
authors.initials: VG
authors.lastname: Chasnyk
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D002675:Child, Preschool; D056587:Cryopyrin-Associated Periodic Syndromes / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D008297:Male; D017211:Treatment Failure
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; C502936:tocilizumab